Nephron Research upgraded Molina Healthcare (MOH) to Buy from Hold with a $250 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Cantor Fitzgerald says CMS guidance reinforces 2026 as ‘difficult for Medicaid’
- Republican lawmakers have yet to agree on healthcare plan, WSJ reports
- Trump Weekly: White House postpones healthcare proposal after backlash
- Trump Trade: White House postpones healthcare proposal after backlash
- Speaker Johnson warns House Republicans don’t want ACA subsidies, WSJ says
